To use all functions of this page, please activate cookies in your browser.
my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
23 Current news of Medicago
rss![]() |
You can refine your search further. Select from the filter options on the left to narrow down your results. |
New complex will make vaccines and therapeutics using innovative plant technology
21-May-2015
Medicago announced that Quebec City will be home to its new production complex. The $245 million project will create 200 new high-skilled jobs by 2019, adding to the team of 180 employees already working at Medicago's Quebec City office and laboratories. The project is expected to generate more ...
18-Jan-2012
Medicago Inc. and Cellectis plant sciences, a subsidiary of Cellectis SA announced the signing of a research agreement under which Medicago and Cellectis will collaborate to improve therapeutic proteins expressed from tobacco leaves. "We look forward to working with Cellectis plant sciences to ...
12-Apr-2011
Medicago Inc. announced that it has entered into a research collaboration agreement for the development of a non-influenza vaccine candidate with a top 10 global pharmaceutical company.Under the terms of the research collaboration, Medicago will apply its transient expression system to develop a ...
29-Nov-2010
Medicago Inc. announced an extension to its partnering agreement of July 2009 with Genopole®. Medicago and Genopole® will also work towards the creation a laboratory for research on vaccine and antibody targets of interest for France in terms of public health and biodefense. This laboratory is ...
27-Sep-2010
Medicago Inc. announced it has filed two international patent applications under the Patent Cooperation Treaty (PCT) that broadly cover new methods of preparing plant-derived recombinant proteins and VLPs. "The extraction and purification of recombinant proteins and complex structures such as ...
Medicago to develop a vaccine facility in Research Triangle Park, North Carolina
12-Aug-2010
Medicago USA Inc., a wholly owned subsidiary of Medicago Inc., announced that it has been awarded a $21 Million grant from the Defense Advanced Research Projects Agency (DARPA), Broad Agency Announcement (BAA), Defense Sciences Research & Technology to demonstrate the scalable manufacturing of ...
19-Mar-2010
Medicago Inc. announced that it has signed a Memorandum of Understanding with Niigata TLO/NBRP/KUTLO-NITT ("NITT Partners") to discuss and negotiate an agreement to commercialize Medicago's pandemic and seasonal influenza VLP-based vaccines in Japan and other territories. For several years, NITT ...
13-Oct-2009
Medicago Inc. announced that it has been awarded a proof of concept contract by the U.S. Army Research, Development and Engineering Command laboratory specifically the Edgewood Chemical Biological Center ("ECBC") Research & Technology Directorate. Medicago will work with ECBC to investigate the ...
27-Aug-2009
Medicago Inc. announced that it has received clearance from Health Canada to commence a Phase I human clinical trial with its H5N1 Avian Influenza vaccine. Enrollment of volunteers is now underway. The Phase I placebo-controlled, double-blind, dose-escalating study will evaluate safety, ...
25-Aug-2009
Medicago Inc. announced that it has signed a Memorandum of Understanding ("MOU") with Ajanta Pharma Limited to discuss and negotiate an agreement to commercialize Medicago's pandemic and seasonal influenza VLP-based vaccines in India and other territories. Under the terms of the MOU, the parties ...